Other hedge funds and other institutional investors have also modified their holdings of the company. GKV Capital Management Co. Inc. acquired a new position in shares of Pfizer in the 1st quarter valued at about $27,000. North Capital Inc. acquired a new position in shares of Pfizer in the 1st quarter valued at about $28,000. Bayforest Capital Ltd acquired a new position in shares of Pfizer in the 1st quarter valued at about $28,000. Horizon Financial Services LLC acquired a new position in shares of Pfizer in the 1st quarter valued at about $35,000. Finally, WPG Advisers LLC acquired a new position in shares of Pfizer in the 1st quarter valued at about $35,000. 68.36% of the stock is owned by institutional investors and hedge funds.